Xeris Biopharma Holdings annual current ratio
2020
2021
2022
2023
2024
2025
Xeris Biopharma Holdings Current Ratio Growth & History (XERS)
Xeris Biopharma Holdings's current ratio was 2.19 for fiscal 2025.
View full Xeris Biopharma Holdings company overviewXeris Biopharma Holdings annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.19 | 0.52 | +31.39% |
| 2024 | 2024-12-31 | 1.67 | 0.03 | +1.69% |
| 2023 | 2023-12-31 | 1.64 | −0.90 | −35.31% |
| 2022 | 2022-12-31 | 2.54 | 0.73 | +40.66% |
| 2021 | 2021-12-31 | 1.80 | −3.59 | −66.57% |
| 2020 | 2020-12-31 | 5.40 | — | — |
Xeris Biopharma Holdings quarterly current ratio
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q4.23
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.45 | −0.50 | −25.67% |
| Q1 2026 | 2026-03-31 | 2.12 | 0.40 | +23.41% |
| Q4 2025 | 2025-12-31 | 2.19 | 0.52 | +31.39% |
| Q3 2025 | 2025-09-30 | 1.93 | 0.14 | +7.78% |
| Q2 2025 | 2025-06-30 | 1.95 | −0.31 | −13.59% |
| Q1 2025 | 2025-03-31 | 1.72 | — | — |
| Q4 2024 | 2024-12-31 | 1.67 | 0.03 | +1.69% |
| Q3 2024 | 2024-09-30 | 1.79 | −0.03 | −1.49% |
| Q2 2024 | 2024-06-30 | 2.26 | — | — |
| Q4 2023 | 2023-12-31 | 1.64 | −0.90 | −35.31% |
| Q3 2023 | 2023-09-30 | 1.82 | −0.36 | −16.40% |
| Q4 2022 | 2022-12-31 | 2.54 | 0.73 | +40.66% |
| Q3 2022 | 2022-09-30 | 2.17 | −1.16 | −34.88% |
| Q2 2022 | 2022-06-30 | 2.50 | — | — |
| Q1 2022 | 2022-03-31 | 2.67 | — | — |
| Q4 2021 | 2021-12-31 | 1.80 | −3.59 | −66.57% |
| Q3 2021 | 2021-09-30 | 3.34 | — | — |
| Q4 2020 | 2020-12-31 | 5.40 | — | — |
Xeris Biopharma Holdings current ratio trends
Over the last five fiscal years, Xeris Biopharma Holdings's current ratio decreased from 5.40 to 2.19, a change of −3.20. The latest reported quarter, Q2 2026, shows 1.45.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xeris Biopharma Holdings source filings ↗